Palbociclib Intermediates – Vidgastech
At Vidgastech, we specialize in the research, development, and manufacturing of high-quality pharmaceutical intermediates, including those critical to the synthesis of Palbociclib, a leading CDK4/6 inhibitor used in breast cancer treatment. Palbociclib’s therapeutic efficacy relies on a complex chemical structure, built from precisely engineered intermediates that ensure purity, potency, and regulatory compliance at every stage of production.